{"id":"https://openalex.org/W4281850344","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e17543","title":"Long-term survival in newly-diagnosed ovarian cancer patients.","display_name":"Long-term survival in newly-diagnosed ovarian cancer patients.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4281850344","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e17543"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.e17543","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e17543","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.e17543","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057287935","display_name":"Elizabeth A. Szamreta","orcid":"https://orcid.org/0000-0001-7723-3388","observed_orcids":["https://orcid.org/0000-0001-7723-3388"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth A. Szamreta","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ;","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019356105","display_name":"Yeran Li","orcid":"https://orcid.org/0000-0002-9777-7152","observed_orcids":["https://orcid.org/0000-0002-9777-7152"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yeran Li","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ;","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003839820","display_name":"Matthew Monberg","orcid":"https://orcid.org/0009-0006-7462-4782","observed_orcids":["https://orcid.org/0009-0006-7462-4782"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew J. Monberg","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ;","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028772063","display_name":"Megan K. D. Othus","orcid":"https://orcid.org/0000-0001-8176-6371","observed_orcids":["https://orcid.org/0000-0001-8176-6371"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Megan Othus","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA;","institution_ids":["https://openalex.org/I4210089486"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"e17543","last_page":"e17543"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/long-term-survival","display_name":"long-term survival","score":0.9860000014305115},{"id":"https://openalex.org/keywords/mixture-cure-models","display_name":"mixture cure models","score":0.7160000205039978},{"id":"https://openalex.org/keywords/fallopian-tube-cancer","display_name":"fallopian tube cancer","score":0.8289999961853027},{"id":"https://openalex.org/keywords/peritoneal-cancer","display_name":"peritoneal cancer","score":0.984000027179718},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7440000176429749},{"id":"https://openalex.org/keywords/age","display_name":"age","score":0.4959999918937683},{"id":"https://openalex.org/keywords/tumor-stage","display_name":"tumor stage","score":0.7919999957084656},{"id":"https://openalex.org/keywords/tumor-grade","display_name":"tumor grade","score":0.8970000147819519},{"id":"https://openalex.org/keywords/ecog-performance-status","display_name":"ECOG performance status","score":0.9819999933242798},{"id":"https://openalex.org/keywords/platinum-sensitivity","display_name":"platinum sensitivity","score":0.9710000157356262},{"id":"https://openalex.org/keywords/platinum-resistance","display_name":"platinum resistance","score":0.3779999911785126},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.45500001311302185},{"id":"https://openalex.org/keywords/newly-diagnosed-ovarian-cancer","display_name":"newly diagnosed ovarian cancer","score":0.6679999828338623},{"id":"https://openalex.org/keywords/patient-characteristics","display_name":"patient characteristics","score":0.3050000071525574}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.901595950126648},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6350226402282715},{"id":"https://openalex.org/C2780558122","wikidata":"https://www.wikidata.org/wiki/Q7310803","display_name":"Relative survival","level":4,"score":0.591063916683197},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5504176020622253},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.5291113257408142},{"id":"https://openalex.org/C164465091","wikidata":"https://www.wikidata.org/wiki/Q7248371","display_name":"Prognostic variable","level":3,"score":0.5231258273124695},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5010967254638672},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.4898809790611267},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.434447705745697},{"id":"https://openalex.org/C2778527826","wikidata":"https://www.wikidata.org/wiki/Q1787017","display_name":"Cancer registry","level":3,"score":0.22320342063903809}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.e17543","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e17543","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.e17543","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3106269486","https://openalex.org/W3029616903","https://openalex.org/W4410812953","https://openalex.org/W3035315520","https://openalex.org/W2749889037","https://openalex.org/W3102192901","https://openalex.org/W2767472502","https://openalex.org/W4295818078","https://openalex.org/W3127465409","https://openalex.org/W2081027801"],"abstract_inverted_index":{"e17543":[0],"Background:":[1],"A":[2],"proportion":[3],"of":[4,41,73,104,149,173,332],"women":[5,98],"with":[6,11,99,117,176,185,206],"ovarian":[7,75,160,333],"cancer,":[8],"even":[9],"those":[10],"advanced-stage":[12],"disease,":[13,351,354],"will":[14],"experience":[15],"long-term":[16,37,48,60,145,177,212,224,315,337,339,371],"survival":[17,49,61,146,178,209,213,225,316,372],"post":[18],"diagnosis.":[19],"Mixture":[20,137],"cure":[21,138],"modeling":[22],"provides":[23],"insight":[24],"into":[25],"factors":[26],"related":[27],"to":[28,45,52,142,344,360,369],"both":[29],"short-term":[30],"recurrence":[31],"and":[32,51,58,63,66,113,156,163,187,201,270,284,326,347],"death":[33],"as":[34,36,151,153,379],"well":[35],"survival.":[38],"The":[39,79,211,223],"goals":[40],"this":[42],"study":[43,95],"were":[44,127,140,204,336,341],"estimate":[46,143],"the":[47,59,92,144,304],"rate,":[50],"evaluate":[53,370],"associations":[54],"between":[55,111],"patient":[56,166,319],"characteristics":[57,320],"rate":[62,147,214,226],"landmark":[64,189],"5-":[65,186,283],"10-":[67],"year":[68],"survival,":[69],"in":[70,91,215,296,314,373],"a":[71,100,118,367],"sample":[72,133],"newly-diagnosed":[74],"cancer":[76,110,309,334],"patients.":[77],"Methods:":[78],"Tempus":[80],"EMR":[81],"dataset":[82],"contains":[83],"patients":[84,276,335,374],"from":[85],"academic":[86],"&":[87,168],"community":[88],"oncology":[89],"centers":[90],"U.S.":[93],"This":[94],"included":[96],"adult":[97],"new":[101],"primary":[102],"diagnosis":[103],"ovarian,":[105],"fallopian":[106],"tube,":[107],"or":[108,125,358],"peritoneal":[109],"2000":[112],"2020.":[114],"Women":[115],"treated":[116],"poly-ADP":[119],"ribose":[120],"polymerase":[121],"inhibitor":[122],"(PARPi),":[123],"pembrolizumab,":[124],"nivolumab":[126],"excluded":[128],"(n":[129],"=":[130,135,288,292],"947;":[131],"final":[132],"size":[134],"6,598).":[136],"models":[139,184],"used":[141],"(probability":[148],"living":[150],"long":[152],"an":[154],"age-":[155],"gender-matched":[157],"person":[158],"without":[159],"cancer),":[161],"overall":[162,208],"stratified":[164],"by":[165,308],"demographic":[167],"clinical":[169,324],"characteristics.":[170],"Relative":[171],"importance":[172],"variables":[174],"associated":[175,205],"was":[179,218,227],"evaluated":[180],"using":[181],"logistic":[182,298],"regression":[183,299],"10-year":[188,285],"outcomes.":[190],"Results:":[191],"Younger":[192],"age,":[193],"earlier":[194,349],"stage,":[195],"lower":[196],"grade,":[197],"favorable":[198],"ECOG":[199,260],"score,":[200],"platinum":[202,271,274,301],"sensitivity":[203,302,359],"better":[207,355],"(OS).":[210],"our":[216],"model":[217],"25.0%":[219],"(95%":[220],"CI:":[221],"21.5-28.9).":[222],"higher":[228],"for":[229,323],"age":[230,234],"<":[231],"65":[232],"vs.":[233,238,242,248,253,257,262,266,273,279],"75+":[235],"[29.0%":[236],"(24.8-33.6)":[237],"10.5%":[239],"(2.9-31.6)],":[240],"early":[241],"advanced":[243],"stage":[244,350],"disease":[245],"[62.0%":[246],"(41.4-78.9)":[247],"17.8%":[249],"(14.1-22.2)],":[250],"grade":[251,353],"1-2":[252],"3-4":[254,263],"[31.4%":[255],"(12.1-60.3)":[256],"20.4%":[258],"(14.6-27.8)],":[259],"0-2":[261],"[26.1%":[264],"(21.4-31.3)":[265],"2.6%":[267],"(0.05-":[268],"56.5)],":[269],"sensitive":[272],"resistant":[275],"[47.5%":[277],"(43.1-51.9)":[278],"9.4%":[280],"(7.0-12.5)].":[281],"Analyzing":[282],"landmarks":[286],"[n":[287],"3,944":[289],"(59.8%),":[290],"n":[291],"3,107":[293],"(47.1%),":[294],"respectively]":[295],"multivariable":[297],"models,":[300],"had":[303],"strongest":[305],"association,":[306],"followed":[307],"stage.":[310],"Conclusions:":[311],"Understanding":[312],"differences":[313],"based":[317],"on":[318,375],"is":[321],"important":[322],"decision-making":[325],"personalizing":[327],"treatment.":[328],"Overall,":[329],"one":[330],"quarter":[331],"survivors;":[338],"survivors":[340],"more":[342],"likely":[343],"be":[345],"younger":[346],"have":[348],"low":[352],"performance":[356],"status,":[357],"platinum-based":[361],"therapy.":[362],"These":[363],"results":[364],"also":[365],"provide":[366],"baseline":[368],"newer":[376],"therapies":[377],"such":[378],"PARPi":[380],"when":[381],"sufficient":[382],"follow-up":[383],"data":[384],"are":[385],"available.":[386]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2022-06-13T00:00:00"}